Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice

Tseng H-C, Arasteh A, Paranjpe A, Teruel A, Yang W, Behel A, Alva JA, Walter G, Head C, Ishikawa T, Herschman HR, Cacalano N, Pyle AD, Park N-H, Jewett A (2010) Increased lysis of stem cells but not their differentiated cells by Natural Killer cells; de-differentiation or reprogramming activates NK cells. PLoS ONE. doi:10.1371/journal.pone.0011590 Jewett A, Man Y-G, Tseng H-C (2013) Dual functions of Natural Killer cells in selection and differentiation of stem cells; role in regulation of inflammation and regeneration of tissues. J Cancer 4(1):12–24. doi:10.7150/jca.5519 Ames E, Canter RJ, Grossenbacher SK, Mac S, Chen M, Smith RC, Hagino T, Perez-Cunningham J, Sckisel GD, Urayama S, Monjazeb AM, Fragoso RC, Sayers TJ, Murphy WJ (2015) NK cells preferentially target tumor cells with a cancer stem cell phenotype. J Immunol 195(8):4010–4019. doi:10.4049/jimmunol.1500447 Jewett A, Cavalcanti M, Bonavida B (1997) Pivotal role of endogenous TNF-alpha in the induction of functional inactivation and apoptosis in NK cells. J Immunol 159(10):4815–4822 Jewett A, Bonavida B (1995) Target-induced anergy of Natural Killer cytotoxic function is restricted to the NK-target conjugate subset. Cell Immunol 160(1):91–97 Jewett A, Bonavida B (2000) MHC-Class I antigens regulate both the function and the survival of human peripheral blood NK cells: role of endogenously secreted TNF-alpha. Clin Immunol 96(1):19–28 Jewett A, Cacalano NA, Head C, Teruel A (2006) Coengagement of CD16 and CD94 receptors mediates secretion of chemokines and induces apoptotic death of naive Natural Killer cells. Clin Cancer Res 12(7 Pt 1):1994–2003 Jewett A, Teruel A, Romero M, Head C, Cacalano N (2008) Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab’)2 fragment of anti-CD16 antibody. Cancer Immunol Immunother: CII 57(7):1053–1066 Jewett A, Bonavida B (1996) Target-induced inactivation and cell death by apoptosis in a subset of human NK cells. J Immunol 156(3):907–915 Tseng H-C, Bui V, Man Y-G, Cacalano N, Jewett A (2014) Induction of split anergy conditions Natural Killer cells to promote differentiation of stem cells through cell–cell contact and secreted factors. Front Immunol 5:269. doi:10.3389/fimmu.2014.00269 Tseng HC, Cacalano N, Jewett A (2015) Split anergized Natural Killer cells halt inflammation by inducing stem cell differentiation, resistance to NK cell cytotoxicity and prevention of cytokine and chemokine secretion. Oncotarget 6(11):8947–8959 Mestas J, Hughes CC (2004) Of mice and not men: differences between mouse and human immunology. J Immunol 172(5):2731–2738 Rongvaux A, Takizawa H, Strowig T, Willinger T, Eynon EE, Flavell RA, Manz MG (2013) Human hemato-lymphoid system mice: current use and future potential for medicine. Annu Rev Immunol 31:635–674. doi:10.1146/annurev-immunol-032712-095921 Cooper MA, Fehniger TA, Caligiuri MA (2001) The biology of human Natural Killer-cell subsets. Trends Immunol 22(11):633–640 Yokoyama WM, Kim S, French AR (2004) The dynamic life of Natural Killer cells. Annu Rev Immunol 22:405–429. doi:10.1146/annurev.immunol.22.012703.104711 Yoshizawa K, Nakajima S, Notake T, Miyagawa S, Hida S, Taki S (2011) IL-15-high-responder developing NK cells bearing Ly49 receptors in IL-15 −/− mice. J Immunol 187(10):5162–5169. doi:10.4049/jimmunol.1101561 Tseng HC, Arasteh A, Kaur K, Kozlowska A, Topchyan P, Jewett A (2015) Differential cytotoxicity but augmented IFN-gamma secretion by NK cells after interaction with monocytes from humans, and those from wild type and myeloid-specific COX-2 knockout mice. Front Immunol 6:259. doi:10.3389/fimmu.2015.00259 Bosma GC, Custer RP, Bosma MJ (1983) A severe combined immunodeficiency mutation in the mouse. Nature 301(5900):527–530 Isaacson JH, Cattanach BM (1962) [Report]. Mouse News Lett 27:31 Levy EM, Yonkosky D, Schmid K, Cooperband SR (1977) Enrichment of the murine Natural Killer (NK) and mitogen induced cellular cytotoxicity (MICC) cells using preparative free-flow high voltage electrophoresis. Prep Biochem 7(6):467–478. doi:10.1080/00327487708065514 Nomura T, Watanabe T, Habu S (2008) Humanized mice. Preface. Curr Top Microbiol Immunol 324:v–vi Phillips RA, Jewett MA, Gallie BL (1989) Growth of human tumors in immune-deficient scid mice and nude mice. Curr Top Microbiol Immunol 152:259–263 Kataoka S, Satoh J, Fujiya H, Toyota T, Suzuki R, Itoh K, Kumagai K (1983) Immunologic aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity. Diabetes 32(3):247–253 Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL et al (1995) Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 154(1):180–191 Baxter AG, Cooke A (1993) Complement lytic activity has no role in the pathogenesis of autoimmune diabetes in NOD mice. Diabetes 42(11):1574–1578 Greiner DL, Hesselton RA, Shultz LD (1998) SCID mouse models of human stem cell engraftment. Stem Cells 16(3):166–177. doi:10.1002/stem.160166 Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S, Kotb M, Gillies SD, King M, Mangada J, Greiner DL, Handgretinger R (2005) Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174(10):6477–6489 Shultz LD, Brehm MA, Garcia-Martinez JV, Greiner DL (2012) Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol 12(11):786–798. doi:10.1038/nri3311 Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, Watanabe T, Akashi K, Shultz LD, Harada M (2005) Development of functional human blood and immune systems in NOD/SCID/IL2 receptor gamma chain(null) mice. Blood 106(5):1565–1573. doi:10.1182/blood-2005-02-0516 Shultz LD, Ishikawa F, Greiner DL (2007) Humanized mice in translational biomedical research. Nat Rev Immunol 7(2):118–130. doi:10.1038/nri2017 Ito A, Ishida T, Yano H, Inagaki A, Suzuki S, Sato F, Takino H, Mori F, Ri M, Kusumoto S, Komatsu H, Iida S, Inagaki H, Ueda R (2009) Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse model. Cancer Immunol Immunother 58(8):1195–1206. doi:10.1007/s00262-008-0632-0 King MA, Covassin L, Brehm MA, Racki W, Pearson T, Leif J, Laning J, Fodor W, Foreman O, Burzenski L, Chase TH, Gott B, Rossini AA, Bortell R, Shultz LD, Greiner DL (2009) Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin Exp Immunol 157(1):104–118. doi:10.1111/j.1365-2249.2009.03933.x Shimizu S, Hong P, Arumugam B, Pokomo L, Boyer J, Koizumi N, Kittipongdaja P, Chen A, Bristol G, Galic Z, Zack JA, Yang O, Chen IS, Lee B, An DS (2010) A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model. Blood 115(8):1534–1544. doi:10.1182/blood-2009-04-215855 Vatakis DN, Bristol GC, Kim SG, Levin B, Liu W, Radu CG, Kitchen SG, Zack JA (2012) Using the BLT humanized mouse as a stem cell based gene therapy tumor model. J Vis Exp 70:e4181. doi:10.3791/4181 Stoddart CA, Maidji E, Galkina SA, Kosikova G, Rivera JM, Moreno ME, Sloan B, Joshi P, Long BR (2011) Superior human leukocyte reconstitution and susceptibility to vaginal HIV transmission in humanized NOD-scid IL-2Rgamma(−/−) (NSG) BLT mice. Virology 417(1):154–160. doi:10.1016/j.virol.2011.05.013 Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, Lanzavecchia A, Manz MG (2004) Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304(5667):104–107. doi:10.1126/science.1093933 Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, Ueyama Y, Koyanagi Y, Sugamura K, Tsuji K, Heike T, Nakahata T (2002) NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100(9):3175–3182. doi:10.1182/blood-2001-12-0207 Strowig T, Chijioke O, Carrega P, Arrey F, Meixlsperger S, Rämer PC, Ferlazzo G, Münz C (2010) Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence. Blood 116(20):4158–4167. doi:10.1182/blood-2010-02-270678 Olesen R, Wahl A, Denton PW, Garcia JV (2011) Immune reconstitution of the female reproductive tract of humanized BLT mice and their susceptibility to human immunodeficiency virus infection. J Reprod Immunol 88(2):195–203. doi:10.1016/j.jri.2010.11.005 Denton PW, Olesen R, Choudhary SK, Archin NM, Wahl A, Swanson MD, Chateau M, Nochi T, Krisko JF, Spagnuolo RA, Margolis DM, Garcia JV (2012) Generation of HIV latency in humanized BLT mice. J Virol 86(1):630–634. doi:10.1128/JVI.06120-11 Manz MG (2007) Human-hemato-lymphoid-system mice: opportunities and challenges. Immunity 26(5):537–541. doi:10.1016/j.immuni.2007.05.001 Vatakis DN, Koya RC, Nixon CC, Wei L, Kim SG, Avancena P, Bristol G, Baltimore D, Kohn DB, Ribas A, Radu CG, Galic Z, Zack JA (2011) Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells. Proc Natl Acad Sci USA 108(51):E1408–E1416. doi:10.1073/pnas.1115050108 Kwant-Mitchell A, Pek EA, Rosenthal KL, Ashkar AA (2009) Development of functional human NK cells in an immunodeficient mouse model with the ability to provide protection against tumor challenge. PLoS ONE 4(12):e8379. doi:10.1371/journal.pone.0008379 Pek EA, Chan T, Reid S, Ashkar AA (2011) Characterization and IL-15 dependence of NK cells in humanized mice. Immunobiology 216(1–2):218–224. doi:10.1016/j.imbio.2010.04.008 Chen Q, Khoury M, Chen J (2009) Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice. Proc Natl Acad Sci USA 106(51):21783–21788. doi:10.1073/pnas.0912274106 Huntington ND, Legrand N, Alves NL, Jaron B, Weijer K, Plet A, Corcuff E, Mortier E, Jacques Y, Spits H, Di Santo JP (2009) IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med 206(1):25–34. doi:10.1084/jem.20082013 Andre MC, Erbacher A, Gille C, Schmauke V, Goecke B, Hohberger A, Mang P, Wilhelm A, Mueller I, Herr W, Lang P, Handgretinger R, Hartwig UF (2010) Long-term human CD34+ stem cell-engrafted nonobese diabetic/SCID/IL-2R gamma(null) mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells. J Immunol 185(5):2710–2720. doi:10.4049/jimmunol.1000583 Mrozek E, Anderson P, Caligiuri MA (1996) Role of interleukin-15 in the development of human CD56+ Natural Killer cells from CD34+ hematopoietic progenitor cells. Blood 87(7):2632–2640 Sato T, Laver JH, Aiba Y, Ogawa M (1999) NK cell colony formation from human fetal thymocytes. Exp Hematol 27(4):726–733 Vosshenrich CA, Ranson T, Samson SI, Corcuff E, Colucci F, Rosmaraki EE, Di Santo JP (2005) Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J Immunol 174(3):1213–1221 Fischer A, Le Deist F, Hacein-Bey-Abina S, Andre-Schmutz I, Basile Gde S, de Villartay JP, Cavazzana-Calvo M (2005) Severe combined immunodeficiency. A model disease for molecular immunology and therapy. Immunol Rev 203:98–109. doi:10.1111/j.0105-2896.2005.00223.x Ferlazzo G, Pack M, Thomas D, Paludan C, Schmid D, Strowig T, Bougras G, Muller WA, Moretta L, Munz C (2004) Distinct roles of IL-12 and IL-15 in human Natural Killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci USA 101(47):16606–16611. doi:10.1073/pnas.0407522101 Strowig T, Chijioke O, Carrega P, Arrey F, Meixlsperger S, Ramer PC, Ferlazzo G, Munz C (2010) Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence. Blood 116(20):4158–4167. doi:10.1182/blood-2010-02-270678 Wege AK, Ernst W, Eckl J, Frankenberger B, Vollmann-Zwerenz A, Männel DN, Ortmann O, Kroemer A, Brockhoff G (2011) Humanized tumor mice—a new model to study and manipulate the immune response in advanced cancer therapy. Int J Cancer 129(9):2194–2206. doi:10.1002/ijc.26159 Shurin MR, Umansky V, Malyguine A, Hurwitz AA, Apte RN, Whiteside T, Jewett A, Thanavala Y, Murphy WJ (2014) Cellular and molecular pathways in the tumor immunoenvironment: 3rd Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, 22–25 April 2013, Krakow, Poland. Cancer Immunol Immunother 63(1):73–80. doi:10.1007/s00262-013-1501-z Raulet DH, Guerra N (2009) Oncogenic stress sensed by the immune system: role of Natural Killer cell receptors. Nat Rev Immunol 9(8):568–580. doi:10.1038/nri2604 Pietra G, Manzini C, Rivara S, Vitale M, Cantoni C, Petretto A, Balsamo M, Conte R, Benelli R, Minghelli S, Solari N, Gualco M, Queirolo P, Moretta L, Mingari MC (2012) Melanoma cells inhibit Natural Killer cell function by modulating the expression of activating receptors and cytolytic activity. Cancer Res 72(6):1407–1415. doi:10.1158/0008-5472.CAN-11-2544 Garcia-Iglesias T, Del Toro-Arreola A, Albarran-Somoza B, Del Toro-Arreola S, Sanchez-Hernandez PE, Ramirez-Duenas MG, Balderas-Pena LM, Bravo-Cuellar A, Ortiz-Lazareno PC, Daneri-Navarro A (2009) Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions. BMC Cancer 9:186. doi:10.1186/1471-2407-9-186 Peng YP, Zhang JJ, Liang WB, Tu M, Lu ZP, Wei JS, Jiang KR, Gao WT, Wu JL, Xu ZK, Miao Y, Zhu Y (2014) Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates Natural Killer cell dysfunction. BMC Cancer 14:738. doi:10.1186/1471-2407-14-738 Mamessier E, Sylvain A, Bertucci F, Castellano R, Finetti P, Houvenaeghel G, Charaffe-Jaufret E, Birnbaum D, Moretta A, Olive D (2011) Human breast tumor cells induce self-tolerance mechanisms to avoid NKG2D-mediated and DNAM-mediated NK cell recognition. Cancer Res 71(21):6621–6632. doi:10.1158/0008-5472.CAN-11-0792 Chen Z, Malhotra PS, Thomas GR, Ondrey FG, Duffey DC, Smith CW, Enamorado I, Yeh NT, Kroog GS, Rudy S, McCullagh L, Mousa S, Quezado M, Herscher LL, Van Waes C (1999) Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 5(6):1369–1379 Tseng HC, Kanayama K, Kaur K, Park SH, Park S, Kozlowska A, Sun S, McKenna CE, Nishimura I, Jewett A (2015) Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo: role in osteoclast-mediated NK cell activation. Oncotarget 6(24):20002–20025 Cooper MA, Elliott JM, Keyel PA, Yang L, Carrero JA, Yokoyama WM (2009) Cytokine-induced memory-like Natural Killer cells. Proc Natl Acad Sci USA 106(6):1915–1919. doi:10.1073/pnas.0813192106 Kelland LR (2004) Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development. Eur J Cancer 40(6):827–836. doi:10.1016/j.ejca.2003.11.028 Nonoyama S, Smith FO, Bernstein ID, Ochs HD (1993) Strain-dependent leakiness of mice with severe combined immune deficiency. J Immunol 150(9):3817–3824 Shultz LD, Goodwin N, Ishikawa F, Hosur V, Lyons BL, Greiner DL (2014) Human cancer growth and therapy in immunodeficient mouse models. Cold Spring Harb Protoc 7:694–708. doi:10.1101/pdb.top073585